KNF approves Polish Stem Cell Bank prospectus

Poland's financial watchdog (KNF) has approved the prospectus from the Polish Stem Cell Bank (Polski Bank Komórek Macierzystych) to issue A, B, C, D, E, F, G, H, I, J series shares. The investment companies are mBank Brokerage House and Haitong Bank. An offer is planned for the first half of 2016, but the final decision on the date will depend on the situation on the market, a company press release read. In 2015, Polish Stem Cell Bank reported sales revenue of PLN 105 million, EBITDA of PLN 27 million and net profits of PLN 18 million.